BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 19656076)

  • 1. The effect of deoxyschisandrin on blood tacrolimus levels: a case report.
    Jiang W; Wang X; Kong L
    Immunopharmacol Immunotoxicol; 2010 Mar; 32(1):177-8. PubMed ID: 19656076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of a liquid chromatography-mass spectrometric assay for tacrolimus in liver biopsies after hepatic transplantation: correlation with histopathologic staging of rejection.
    Capron A; Lerut J; Verbaandert C; Mathys J; Ciccarelli O; Vanbinst R; Roggen F; De Reyck C; Lemaire J; Wallemacq PE
    Ther Drug Monit; 2007 Jun; 29(3):340-8. PubMed ID: 17529892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Living donor liver transplant recipients achieve relatively higher immunosuppressant blood levels than cadaveric recipients.
    Trotter JF; Stolpman N; Wachs M; Bak T; Kugelmas M; Kam I; Everson GT
    Liver Transpl; 2002 Mar; 8(3):212-8. PubMed ID: 11910565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orthotopic liver transplantation using low-dose tacrolimus and sirolimus.
    McAlister VC; Peltekian KM; Malatjalian DA; Colohan S; MacDonald S; Bitter-Suermann H; MacDonald AS
    Liver Transpl; 2001 Aug; 7(8):701-8. PubMed ID: 11510015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between everolimus and tacrolimus in renal transplant recipients: a pharmacokinetic controlled trial.
    Pascual J; del Castillo D; Cabello M; Pallardó L; Grinyó JM; Fernández AM; Brunet M
    Transplantation; 2010 Apr; 89(8):994-1000. PubMed ID: 20335831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
    Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR
    Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeating intraportal donor-specific transfusion may induce tolerance following adult living-related donor liver transplantation.
    Sato Y; Ichida T; Watanabe H; Yamamoto S; Oya H; Nakatsuka H; Kobayashi T; Watanabe T; Kameyama H; Hatakeyama K
    Hepatogastroenterology; 2003; 50(51):601-6. PubMed ID: 12828042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic drug monitoring of tacrolimus in early stage after heart transplantation.
    Aidong W; Zhenjie C; Tong L; Lei Z; Yin W; Shanqi Z; Liping T
    Transplant Proc; 2004 Oct; 36(8):2388-9. PubMed ID: 15561258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pomelo-induced increase in the blood level of tacrolimus in a renal transplant patient.
    Egashira K; Fukuda E; Onga T; Yogi Y; Matsuya F; Koyabu N; Ohtani H; Sawada Y
    Transplantation; 2003 Apr; 75(7):1057. PubMed ID: 12698101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral tacrolimus bioavailability is increased after right split liver transplantation.
    Wilberg J; Küpper B; Thrum K; Bärthel E; Koch A; Settmacher U; Kornberg A
    Transplant Proc; 2007 Dec; 39(10):3237-8. PubMed ID: 18089362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of steroid-free immunosuppression with tacrolimus and daclizumab in liver transplant recipients: 6-year follow-up in a single center.
    Foroncewicz B; Mucha K; Ryszkowska E; Ciszek M; Ziółkowski J; Porowski D; Krawczyk M; Paczek L
    Transplant Proc; 2009 Oct; 41(8):3103-6. PubMed ID: 19857686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of cyclosporine microemulsion and tacrolimus in 39 recipients of living donor liver transplantation.
    Tanaka K; Lake J; Villamil F; Levy G; Marotta P; Mies S; de Hemptinne B; Moench C
    Liver Transpl; 2005 Nov; 11(11):1395-402. PubMed ID: 16237691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No-load sirolimus with tacrolimus and steroids is safe and effective in renal transplantation.
    Tellis V; Schechner R; Mallis M; Rosegreen S; Glicklich D; Moore N; Greenstein S
    Transplant Proc; 2005 Mar; 37(2):906-8. PubMed ID: 15848571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial comparing renal function in older kidney transplant patients following delayed versus immediate tacrolimus administration.
    Andrés A; Budde K; Clavien PA; Becker T; Kessler M; Pisarski P; Fornara P; Burmeister D; Hené RJ; Cassuto-Viguier E;
    Transplantation; 2009 Nov; 88(9):1101-8. PubMed ID: 19898206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamic analysis of tacrolimus and cyclosporine in living-donor liver transplant patients.
    Fukudo M; Yano I; Masuda S; Fukatsu S; Katsura T; Ogura Y; Oike F; Takada Y; Tanaka K; Inui K
    Clin Pharmacol Ther; 2005 Aug; 78(2):168-81. PubMed ID: 16084851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, prospective, pharmacoeconomic trial of neoral 2-hour postdose concentration monitoring versus tacrolimus trough concentration monitoring in de novo liver transplant recipients.
    Shenoy S; Hardinger KL; Crippin J; Korenblat K; Lisker-Melman M; Lowell JA; Chapman W
    Liver Transpl; 2008 Feb; 14(2):173-80. PubMed ID: 18236391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo autoimmune hepatitis after living donor liver transplantation in a 25-day-old newborn baby: a case report.
    Oya H; Sato Y; Yamamoto S; Kobayashi T; Watanabe T; Kokai H; Hatakeyama K
    Transplant Proc; 2009; 41(1):433-4. PubMed ID: 19249573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
    Levy G; Grazi GL; Sanjuan F; Wu Y; Mühlbacher F; Samuel D; Friman S; Jones R; Cantisani G; Villamil F; Cillo U; Clavien PA; Klintmalm G; Otto G; Pollard S; McCormick PA
    Liver Transpl; 2006 Oct; 12(10):1464-72. PubMed ID: 17004259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing tacrolimus therapy in the maintenance of renal allografts: 12-month results.
    Bolin P; Shihab FS; Mulloy L; Henning AK; Gao J; Bartucci M; Holman J; First MR;
    Transplantation; 2008 Jul; 86(1):88-95. PubMed ID: 18622283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary immunosuppression regimen of rapid steroid withdrawal after living related liver transplantation: a single-center experience.
    Toyoki Y; Hakamada K; Narumi S; Totsuka E; Nara M; Ono H; Ishizawa Y; Sasaki M
    Transplant Proc; 2004 Oct; 36(8):2279-81. PubMed ID: 15561218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.